Literature DB >> 25729063

Validation of the LET classification.

R H W Strijkers1, C W K P Arnoldussen2, C H A Wittens3.   

Abstract

INTRODUCTION: Acute thrombus removal therapies may reduce post-thrombotic syndrome in certain deep venous thrombosis patients. The LET classification is designed to identify patients at high risk for developing post-thrombotic syndrome in the acute phase using thrombus location and extent. This study evaluates the use of the LET classification to predict post-thrombotic syndrome in a cohort of patients after deep venous thrombosis.
METHODS: A cohort of 660 deep venous thrombosis patients was invited to participate and fill out a questionnaire with Quality of life questionnaires, basic information, a modified self-assessment version of the Villalta scale for post-thrombotic syndrome and potential confounders. Original data on thrombus extension was available, and the LET classes were determined. Obtained information was analysed using ANOVA and in a multiple logistic regression model to correct for confounders. All different LET classes were compared to post-thrombotic syndrome occurrence, post-thrombotic syndrome prediction and disease specific quality of life scores (VEINES-Sym/Qol).
RESULTS: Three hundred and fifteen patients responded, and in 309 a post-thrombotic syndrome score was distilled. LET I,II,III (n = 63) had an odds ratio of 3.4(1.2-9.2) for predicting severe post-thrombotic syndrome, and LET II (n = 17) had an odds ratio of 5.1(1.3-20.8) compared to LET class I (n = 97). Both the VEINES-Sym and VEINES-Qol score were significantly lower for LET I,II,III compared to LET I, and LET II compared to LET I.
CONCLUSION: The LET classification can be used to classify patients according to acute thrombus location and extent. Extensive and centrally located (LET I,II,III) deep venous thrombosis showed the highest probability in developing severe post-thrombotic syndrome and lower disease specific quality of life.
© The Author(s) 2015 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav.

Entities:  

Keywords:  Deep venous thrombosis; post-thrombotic syndrome; quality of life; scoring system

Mesh:

Year:  2015        PMID: 25729063     DOI: 10.1177/0268355515569133

Source DB:  PubMed          Journal:  Phlebology        ISSN: 0268-3555            Impact factor:   1.740


  5 in total

1.  Endovascular stent placement for chronic post-thrombotic symptomatic ilio-femoral venous obstructive lesions: a single-center study of safety, efficacy and quality-of-life improvement.

Authors:  Marie-Tiphaine Falcoz; Nicolas Falvo; Serge Aho-Glélé; Emmanuel Demaistre; Christophe Galland; Sylvain Favelier; Pierre Pottecher; Olivier Chevallier; Bernard Bonnotte; Sylvain Audia; Maxime Samson; Béatrice Terriat; Marco Midulla; Romaric Loffroy
Journal:  Quant Imaging Med Surg       Date:  2016-08

Review 2.  Pharmacomechanical thrombectomy for iliofemoral deep vein thrombosis.

Authors:  Lindsay Robertson; Olivia McBride; Anne Burdess
Journal:  Cochrane Database Syst Rev       Date:  2016-11-04

3.  Iatrogenic IVC Perforation after Successful Catheter-Directed Thrombolysis.

Authors:  Ata Firoozi; Jamal Moosavi; Omid Shafe; Parham Sadeghipour
Journal:  Case Rep Vasc Med       Date:  2017-08-29

4.  Quality of anticoagulant therapy and the incidence of in-stent thrombosis after venous stenting.

Authors:  Pascale Notten; Jorinde H H van Laanen; Pieter Eijgenraam; Mark A F de Wolf; Ralph L M Kurstjens; Hugo Ten Cate; Arina J Ten Cate-Hoek
Journal:  Res Pract Thromb Haemost       Date:  2020-04-08

5.  The short-term outcome of residual thrombus of the lower extremity after pharmacomechanical catheter-directed thrombolysis for deep vein thrombosis.

Authors:  Guang Chen; Qing Wang; Yahong Chen; Xiang Wang; Xiaolong Zhang; Xiang Li; Fei Li; Bin Hu; Haiwei Chu; Dexing Zheng; Wenjun Zhao; Hongkun Zhang
Journal:  Ann Transl Med       Date:  2020-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.